263 related articles for article (PubMed ID: 28289191)
41. The Extracellular Vesicles from the Commensal Staphylococcus Epidermidis ATCC12228 Strain Regulate Skin Inflammation in the Imiquimod-Induced Psoriasis Murine Model.
Gómez-Chávez F; Cedillo-Peláez C; Zapi-Colín LA; Gutiérrez-González G; Martínez-Torres I; Peralta H; Chavez-Galan L; Avila-Calderón ED; Contreras-Rodríguez A; Bartolo-Aguilar Y; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884834
[TBL] [Abstract][Full Text] [Related]
42. Autocrine and Paracrine Regulation of Keratinocyte Proliferation through a Novel Nrf2-IL-36γ Pathway.
Kurinna S; Muzumdar S; Köhler UA; Kockmann T; Auf dem Keller U; Schäfer M; Werner S
J Immunol; 2016 Jun; 196(11):4663-70. PubMed ID: 27183581
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2.
Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ
PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668
[TBL] [Abstract][Full Text] [Related]
44. Role of Interleukin 36γ in Host Defense Against Tuberculosis.
Ahsan F; Moura-Alves P; Guhlich-Bornhof U; Klemm M; Kaufmann SH; Maertzdorf J
J Infect Dis; 2016 Aug; 214(3):464-74. PubMed ID: 27389350
[TBL] [Abstract][Full Text] [Related]
45. The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36γ.
Lian LH; Milora KA; Manupipatpong KK; Jensen LE
J Invest Dermatol; 2012 May; 132(5):1346-53. PubMed ID: 22318382
[TBL] [Abstract][Full Text] [Related]
46. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
[TBL] [Abstract][Full Text] [Related]
47. Persistent expression of interleukin-17 and downstream effector cytokines in recalcitrant psoriatic lesions after ustekinumab treatment.
Kim BR; Kim M; Yang S; Choi CW; Lee KS; Youn SW
J Dermatol; 2021 Jun; 48(6):876-882. PubMed ID: 33860544
[TBL] [Abstract][Full Text] [Related]
48. Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability.
Joo YH; Kim HK; Hak Choi I; Han HM; Lee KJ; Kim TH; Lee SH
Cytokine; 2020 Jan; 125():154798. PubMed ID: 31430658
[TBL] [Abstract][Full Text] [Related]
49. Elevated urinary IL-36γ in patients with active lupus nephritis and response to treatment.
Majumder S; Singh P; Chatterjee R; Pattnaik SS; Aggarwal A
Lupus; 2021 May; 30(6):921-925. PubMed ID: 33593161
[TBL] [Abstract][Full Text] [Related]
50. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
51. Keratinocyte-derived IL-36γ plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes.
Pyo JJ; Ahn S; Jin SH; An S; Lee E; Choi J; Shin JC; Choi H; Kim HJ; Choi D; Noh M
Arch Toxicol; 2019 Aug; 93(8):2307-2320. PubMed ID: 31256213
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-1: a key inflammatory mediator in psoriasis?
Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
[TBL] [Abstract][Full Text] [Related]
53. Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis.
Wang H; Wang S; Li L; Wang X; Liu C; Lu M; Xia Y; Liu Y
Cytokine; 2021 Feb; 138():155391. PubMed ID: 33302223
[TBL] [Abstract][Full Text] [Related]
54. IL-36α and IL-36γ expressions in the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema: A retrospective histopathologic and immunohistochemical study.
Erdem O; Leblebici C; Koku Aksu AE; Erdil D; Kara Polat A; Gürel MS
J Cutan Pathol; 2022 Jan; 49(1):42-48. PubMed ID: 34289144
[TBL] [Abstract][Full Text] [Related]
55. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes.
Müller A; Hennig A; Lorscheid S; Grondona P; Schulze-Osthoff K; Hailfinger S; Kramer D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10088-10093. PubMed ID: 30224457
[TBL] [Abstract][Full Text] [Related]
56. Expression of cathepsins B and L in human lung epithelial cells is regulated by cytokines.
Gerber A; Welte T; Ansorge S; Bühling F
Adv Exp Med Biol; 2000; 477():287-92. PubMed ID: 10849756
[TBL] [Abstract][Full Text] [Related]
57. Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway.
Li Q; Liu S; Li L; Ji X; Wang M; Zhou J
Glia; 2019 Mar; 67(3):438-451. PubMed ID: 30578562
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40.
Xu N; Meisgen F; Butler LM; Han G; Wang XJ; Söderberg-Nauclér C; Ståhle M; Pivarcsi A; Sonkoly E
J Immunol; 2013 Jan; 190(2):678-88. PubMed ID: 23233723
[TBL] [Abstract][Full Text] [Related]
59. Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation.
Hirai T; Kanda T; Sato K; Takaishi M; Nakajima K; Yamamoto M; Kamijima R; Digiovanni J; Sano S
J Immunol; 2013 May; 190(9):4805-11. PubMed ID: 23543761
[TBL] [Abstract][Full Text] [Related]
60. Epidermal IL-15Rα acts as an endogenous antagonist of psoriasiform inflammation in mouse and man.
Bouchaud G; Gehrke S; Krieg C; Kolios A; Hafner J; Navarini AA; French LE; Boyman O
J Exp Med; 2013 Sep; 210(10):2105-17. PubMed ID: 24019554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
